amantadine has been researched along with Syndrome in 18 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Preliminary, uncontrolled research has suggested possible benefit with amantadine for this behavioural syndrome." | 9.08 | N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. ( Bayley, M; Burke, IM; Fawcett, S; Garner, S; Hart, A; Thompson, W; Van Reekum, R, 1995) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 7.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| " Preliminary, uncontrolled research has suggested possible benefit with amantadine for this behavioural syndrome." | 5.08 | N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. ( Bayley, M; Burke, IM; Fawcett, S; Garner, S; Hart, A; Thompson, W; Van Reekum, R, 1995) |
| " A literature review about the spectrum of differential diagnosis in patients with livedo reticularis (especially cutis marmorata and amantadine-induced livedo reticularis) and livedo racemosa (especially Sneddon's syndrome, Divry-van Bogaert syndrome, systemic lupus erythematosus, antiphospholipid antibody syndrome, polyarteritis nodosa, cholesterol embolization syndrome, livedoid vasculopathy and haematological diseases) is provided." | 4.82 | The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. ( Berlit, P; Kraemer, M; Linden, D, 2005) |
| "The authors administered to 18 children with an expressed pharmaco-resistant Lennox-Gastaut syndrome as adjuvant treatment medium doses of amantadine (Viregyt-K, Egyt), 8 mg/kg/day divided into 1-2 portions or L-DOPA (Nakom, Lek) 22 mg/kg/day in 3-4 portions." | 3.67 | [Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome]. ( Slapal, R; Zouhar, A, 1989) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 3.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| "Since the discovery of influenza virus in 1933, many viruses have been reported as the causative agents of acute respiratory infections." | 2.42 | [Influenza and other viral respiratory infections]. ( Kaji, M, 2003) |
| "Psychotic features in patients with Parkinson's Disease usually present as visual hallucinations against a background of cognitive deterioration and dopaminomimetic therapy." | 1.36 | Isolated delusional syndrome in Parkinson's Disease. ( Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horváth, K | 1 |
| Aschermann, Z | 1 |
| Komoly, S | 1 |
| Kovács, A | 1 |
| Kovács, N | 1 |
| Stefanis, N | 1 |
| Bozi, M | 1 |
| Christodoulou, C | 1 |
| Douzenis, A | 1 |
| Gasparinatos, G | 1 |
| Stamboulis, E | 1 |
| Stefanis, C | 1 |
| Stefanis, L | 1 |
| Kaji, M | 1 |
| Kraemer, M | 1 |
| Linden, D | 1 |
| Berlit, P | 1 |
| Rojtman, M | 1 |
| Apter, E | 1 |
| Lahav, S | 1 |
| Tiano, S | 1 |
| Neppe, VM | 1 |
| Zweije-Hofman, IL | 1 |
| van der Zee, HJ | 1 |
| van Nieuwenhuizen, O | 1 |
| Goetz, CG | 1 |
| Tanner, CM | 1 |
| Klawans, HL | 1 |
| Pirovino, M | 1 |
| Meier, J | 1 |
| Meyer, M | 1 |
| Waldmeier, P | 1 |
| Schmid, M | 1 |
| McCarron, MM | 1 |
| Boettger, ML | 1 |
| Peck, JJ | 1 |
| Gradner, W | 1 |
| Schnaberth, G | 1 |
| Auff, E | 1 |
| Van Reekum, R | 1 |
| Bayley, M | 1 |
| Garner, S | 1 |
| Burke, IM | 1 |
| Fawcett, S | 1 |
| Hart, A | 1 |
| Thompson, W | 1 |
| Dike, GL | 1 |
| Iwahashi, J | 1 |
| Tsuji, K | 1 |
| Ishibashi, T | 1 |
| Kajiwara, J | 1 |
| Imamura, Y | 1 |
| Mori, R | 1 |
| Hara, K | 1 |
| Kashiwagi, T | 1 |
| Ohtsu, Y | 1 |
| Hamada, N | 1 |
| Maeda, H | 1 |
| Toyoda, M | 1 |
| Toyoda, T | 1 |
| Slapal, R | 1 |
| Zouhar, A | 1 |
| Davidson, M | 1 |
| Powchik, P | 1 |
| Davis, KL | 1 |
| Soyka, D | 1 |
| Lance, JW | 1 |
| Andrews, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)[NCT00127114] | Phase 4 | 0 participants (Actual) | Interventional | 2005-09-30 | Withdrawn (stopped due to No funding and exclusion criteria were to stringent.) | ||
| Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability: A Randomized, Double-Blind, Placebo-Controlled Trial[NCT00627250] | 76 participants (Actual) | Interventional | 2003-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for amantadine and Syndrome
| Article | Year |
|---|---|
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antag | 2014 |
[Influenza and other viral respiratory infections].
Topics: Amantadine; Antiviral Agents; Common Cold; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidas | 2003 |
The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.
Topics: Adolescent; Adult; Amantadine; Autoantibodies; Cerebrovascular Disorders; Diagnosis, Differential; F | 2005 |
2 trials available for amantadine and Syndrome
| Article | Year |
|---|---|
Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial.
Topics: Adolescent; Adult; Amantadine; Antiparkinson Agents; Benserazide; Drug Combinations; Humans; Levodop | 1982 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
13 other studies available for amantadine and Syndrome
| Article | Year |
|---|---|
Isolated delusional syndrome in Parkinson's Disease.
Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; | 2010 |
[Amantadine in malignant neuroleptic syndrome].
Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Humans; Male; Syndrome | 1981 |
The neuroleptic malignant syndrome. A priority system.
Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Consciousness Disorders; Da | 1984 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; | 1984 |
[Malignant neuroleptics syndrome].
Topics: Adult; Amantadine; Baclofen; Cerebrospinal Fluid; Chromatography, Liquid; Cognition Disorders; Femal | 1984 |
A case of neuroleptic malignant syndrome successfully treated with amantadine.
Topics: Adult; Amantadine; Consciousness Disorders; Fluphenazine; Humans; Male; Malignant Hyperthermia; Musc | 1982 |
[The Steel Richardson Olszewski-syndrome. A report on 3 further cases (author's transl)].
Topics: Amantadine; Biperiden; Bulbar Palsy, Progressive; Dementia; Dysarthria; Humans; Male; Middle Aged; O | 1981 |
Triphasic waves in serotonin syndrome.
Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combination | 1997 |
Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antiviral Agents; Cerebral Infarction; Dr | 2001 |
[Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome].
Topics: Amantadine; Child, Preschool; Epilepsy; Humans; Infant; Levodopa; Syndrome | 1989 |
Pisa syndrome in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amantadine; Drug Therapy, Combination; Dystonia; Haloperidol; Humans; Male; | 1988 |
[Syndrome involving the extrapyramidal motor systems and their drug treatment].
Topics: Amantadine; Antiparkinson Agents; Basal Ganglia Diseases; Dihydroxyphenylalanine; gamma-Aminobutyric | 1974 |
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes.
Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Moveme | 1973 |